The Dilon 6800 Gamma Camera, optimized for molecular breast imaging, boasts Breast-Specific Gamma Imaging (BSGI) as a complement to mammography for early detection of breast cancer.

BSGI is a molecular breast imaging procedure that captures the metabolic activity of breast lesions through radiotracer uptake. A small amount of tracing agent is delivered to a patient, which is then absorbed by the body’s cells. The tracing agent emits invisible gamma rays, which according to the company, are detected by the Dilon 6800 Gamma Camera and translated into a digital image of the breast. Because of their higher metabolic activity, the cancerous cells absorb a greater amount of the tracing agent and are revealed as "hot spots", reportedly helping physicians better differentiate cancerous from noncancerous cells.

November 2007


Additional Content

News | PET Imaging

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
News | Nuclear Imaging

May 5, 2025 — GE HealthCare recently announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance ...

Time May 06, 2025
arrow
News | Radiation Therapy

January 19, 2024 — Treating tumors is a global health issue. In radiotherapy, radiation is used to destroy tumor cells ...

Time January 19, 2024
arrow
Feature | PET Imaging

According to a new report from Transparency Market Research (TMR), PET radiotracers are expected to rise at a CAGR of 8 ...

Time September 05, 2023
arrow
News | Radiology Imaging

August 24, 2023 — Medical imaging via X-rays, CT scans, MRIs and ultrasounds provide health-care professionals with ...

Time August 24, 2023
arrow
Subscribe Now